Skip to content

Evaluating home antibody test kits for the detection of coronavirus (COVID-19) antibodies

Evaluating detection of SARS-CoV-2 antibodies using home test kits (EDSAB-HOME)

Status
Active, not recruiting
Phases
Phase 2
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN56609224
Enrollment
3000
Registered
2020-09-21
Start date
2020-06-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 (SARS-CoV-2 infection) Infections and Infestations COVID-19 (SARS-CoV-2 infection)

Interventions

The study design involves the recruitment of a volunteer cohort (Phase I). which will involve three populations: 1. Individuals at higher risk of past coronavirus infection (healthcare workers) and l

Sponsors

Public Health England
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Currently working on-site at their place of work 2. Aged =18 years 3. Able to read English 4. Has an in-use personal email address and mobile phone

Exclusion criteria

Exclusion criteria: 1. Is currently experiencing COVID-19 compatible symptoms 2. Has experienced COVID-19 compatible symptoms in the last seven days 3. Meets the definition of “exceptionally vulnerable” on medical grounds, including immunosuppression, previous oncological treatments – these people should not be at work anyway 4. Unable to read normal-sized print with glasses 5. Taking part in vaccine studies

Design outcomes

Primary

MeasureTime frame
1. Sensitivity, specificity, positive and negative predictive values of home testing kits (HTKs) for previous SARS-CoV-2 infection measured through patient-reported results when using HTKs observed by research staff compared to results from a "gold standard” reference test (laboratory immunoassay) of venous samples between baseline and 1 year

Secondary

MeasureTime frame
1. Test accuracy of HTKs when read by a trained professional in detecting anti-SARS-CoV-2 antibody, and in detecting previous SARS-CoV-2 infection. Sensitivity, specificity, PPV and NPV will be calculated based on readings by a trained professional in a clinical setting between baseline and 1 year 2. Agreement between untrained users and trained professionals in the reading of HTKs assessed by the proportion of agreement between the reading of the HTK results by: users of the service; trained professional examining a photograph; and a trained professional in a community setting between baseline and 1 year 3. Feasibility of home photographic recording of HTK and whether this enhances accuracy of recording relative to user reading by comparing the results (binary) from trained professionals "in vivo" to trained professionals when reading the picture between baseline and 1 year 4. Acceptability and usability of the HTKs in the population using semi-quantitative interviews in a clinic type setting between baseline and 1 year 5. Acceptability of the instructions and other advice to be provided to people undertaking the tests and to those who have a positive and a negative result following participant interviews and questionnaires undertaken in a clinic setting between baseline and 1 year

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 15, 2026